Presentation
17 March 2023 Monitoring target engagement in vivo via lifetime FRET (Conference Presentation)
Author Affiliations +
Abstract
There is still great need in better characterizing new targeted therapies in vivo, especially prior to clinical translation. In this regard, preclinical molecular imaging is a central tool in the targeted drug development pipeline. However, there is still a lack of imaging platforms that can enable to monitor target engagement, a key in vitro/in vivo parameter to assess the probability of success for a lead compound. Here, we will report on our methodologies to quantify target engagement via lifetime FRET in live subjects. These will include our recent instrumental developments, including large SPAD arrays and structured light strategies, as well as, software developments, including AI based data processing pipelines for 2D/3D imaging and unmixing.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Xavier R. Intes "Monitoring target engagement in vivo via lifetime FRET (Conference Presentation)", Proc. SPIE PC12398, Reporters, Markers, Dyes, Nanoparticles, and Molecular Probes for Biomedical Applications XIV, PC123980K (17 March 2023); https://doi.org/10.1117/12.2655607
Advertisement
Advertisement
KEYWORDS
Fluorescence resonance energy transfer

In vivo imaging

Software development

Artificial intelligence

Data processing

Drug development

Lead

Back to Top